Dr. Lyddane is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3311 E Murdock St
Wichita, KS 67208Phone+1 316-689-9185Fax+1 316-689-9909
Education & Training
Icahn School of Medicine at Mount SinaiResidency, Urology, 2007 - 2011- Icahn School of Medicine at Mount SinaiResidency, Surgery, 2006 - 2007
Weill Cornell MedicineClass of 2006
Certifications & Licensure
CO State Medical License 2024 - 2025
KS State Medical License 2011 - 2024
NY State Medical License 2008 - 2012- American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013
Publications & Presentations
PubMed
- 13 citationsCutting Edge: CD28 Controls Dominant Regulatory T Cell Activity during Active ImmunizationClay Lyddane, Beata U. Gajewska, Elmer Santos, Philip D. King, Glaucia C. Furtado
Journal of Immunology. 2006-03-15 - 87 citationsTargeted elimination of prostate cancer by genetically directed human T lymphocytes.Terence P. Gade, Waleed A. Hassen, Elmer Santos, Gertrude Gunset, Aurore Saudemont
Cancer Research. 2005-10-01 - 26 citationsC-type lectin OCILRP2/Clr-g and its ligand NKRP1f costimulate T cell proliferation and IL-2 production.Wenzhi Tian, Rafael Nunez, Shuhua Cheng, Yumei Ding, Joseph R. Tumang
Cellular Immunology. 2005-03-01
Press Mentions
Via Christi Hospitals Wichita : AMG via Christi Wichita Area's First to Offer Innovative Treatment for Benign Prostatic HyperplasiaJune 6th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
